Menu Close

Monitor 14-Drug Class Profile (LabCorp MedWatch®) – 764422

$116.00

Test Details


Use

Detect and confirm presence of prescribed and illicit drugs


Methodology

Initial testing by immunoassay (IA); confirmation of positive by mass spectrometry (MS)

Test Includes

Amphetamine; barbiturates; benzodiazepines; buprenorphine; cocaine (and metabolite); creatinine; fentanyl; meperidine; methadone; opiate; oxycodone/oxymorphone; pH; phencyclidine (PCP); propoxyphene; specific gravity; tetrahydrocannabinol (THC); tramadol. Note: Contains expanded benzodiazepine confirmation upon reflex of positive screen. Positive expanded benzodiazepine screen includes alpha-hydroxy-alprazolam, alpha-hydroxy-midazolam, alpha-hydroxy-triazolam, 7-aminoclonazepam, hydroxy-ethyl-flurazepam, lorazepam, nordiazepam, oxazepam, and temazepam. Opiate confirmation of positive screen includes hydrocodone, hydromorphone, codeine, and morphine.

Reviews

There are no reviews yet.

Be the first to review “Monitor 14-Drug Class Profile (LabCorp MedWatch®) – 764422”

Your email address will not be published. Required fields are marked *